RXRX — RECURSION PHARMACEUTICALS IN
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 362 SEC-registered investment managers reported holding RXRX (RECURSION PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $1.29B across 350.64M shares. That is +7.4% by share count (+22.16M shares) versus the previous quarter, while reported value moved +28.6%. Ownership is concentrated: the five largest holders account for 48.2% of reported value and the top ten for 65.3%.
Compared with the prior quarter, 55 opened new positions, 138 added to existing stakes, 101 trimmed, 44 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of RECURSION PHARMACEUTICALS IN (RXRX) include BlackRock Inc, Vanguard Group, ARK Invest, ranked by reported 13F value among the 679 institutional holders on this page.
RXRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding RXRX
The superinvestors we track who report RXRX in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 44.75M | $184.80M | 1.07% | Add |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 263 | 308.28M | $1.27B | +7.7% |
| Q2 2026 | 362 | 350.64M | $1.29B | +7.6% |
| Q1 2026 | 349 | 335.88M | $1.03B | +4.5% |
| Q4 2025 | 341 | 324.56M | $1.33B | +13.6% |
| Q3 2025 | 328 | 313.72M | $1.53B | +4.8% |
| Q2 2025 | 335 | 301.07M | $1.52B | +2.5% |
| Q1 2025 | 336 | 294.24M | $1.55B | +4.2% |
| Q4 2024 | 313 | 289.17M | $1.95B | +3.7% |
Over the 8 quarters shown, institutional share counts increased 7% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+13.6%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 53.48M | $220.87M | 0.01% | Add | |
| 44.75M | $184.80M | 1.07% | Add | |
| 35.81M | $147.90M | 0.01% | Add | |
| 30.00M | $123.90M | 0.00% | Add | |
| 23.00M | $95.01M | 0.00% | Add | |
| 18.17M | $75.06M | 0.07% | Reduce | |
| 13.91M | $57.47M | 0.00% | Add | |
| 11.44M | $47.25M | 0.00% | Add | |
| 8.43M | $34.82M | 0.01% | Reduce | |
| 8.26M | $34.09M | 7.36% | Reduce | |
| 6.22M | $25.71M | 0.00% | Add | |
| 4.94M | $20.42M | 0.01% | Reduce | |
| 4.94M | $20.37M | 0.25% | Reduce | |
| 3.55M | $14.67M | 0.01% | Add | |
| 3.54M | $14.61M | 0.00% | Add | |
| 2.68M | $11.06M | 0.68% | Add | |
| 2.50M | $10.31M | 0.10% | Add | |
| 2.39M | $9.87M | 0.00% | New | |
| 2.07M | $8.55M | 0.01% | Reduce | |
| 1.91M | $7.90M | 0.00% | Add | |
| 1.89M | $7.80M | 0.05% | Add | |
| 1.62M | $6.67M | 0.00% | Reduce | |
| 1.09M | $4.51M | 0.06% | Add | |
| 954.80K | $3.94M | 0.00% | Add | |
| 913.34K | $3.77M | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 50.30M | $184.62M | 0.00% | Add | |
| 41.34M | $151.71M | 0.98% | Add | |
| 31.13M | $114.25M | 0.01% | Add | |
| 23.49M | $86.20M | 0.08% | Reduce | |
| 22.77M | $83.55M | 0.00% | Add | |
| 13.82M | $50.72M | 0.00% | New | |
| 13.82M | $50.72M | 0.00% | Add | |
| 13.64M | $50.05M | 0.28% | Hold | |
| 9.64M | $35.39M | 8.97% | Hold | |
| 8.95M | $32.84M | 0.01% | Add | |
| 6.83M | $25.08M | 0.00% | Add | |
| 5.94M | $21.80M | 27.76% | Hold | |
| 5.51M | $20.23M | 0.26% | Add | |
| 5.51M | $20.23M | 0.01% | Add | |
| 4.76M | $17.46M | 0.00% | Add | |
| 4.71M | $17.30M | 0.03% | Add | |
| 4.14M | $15.19M | 0.00% | Add | |
| 4.14M | $15.19M | 0.00% | Add | |
| 4.14M | $15.19M | 0.00% | New | |
| 3.95M | $14.50M | 84.30% | Hold | |
| 3.92M | $14.38M | 0.00% | Reduce | |
| 3.47M | $12.74M | 0.00% | Reduce | |
| 3.35M | $12.31M | 0.02% | Reduce | |
| 3.04M | $11.16M | 0.01% | Add | |
| 2.74M | $10.07M | 0.00% | Add |
Q1 2026 — 25 funds
Q4 2025 — 25 funds
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 39.78M | $194.13M | 0.00% | Add | |
| 33.55M | $163.70M | 0.98% | Add | |
| 31.74M | $154.89M | 0.00% | Add | |
| 23.98M | $117.02M | 0.09% | Reduce | |
| 18.27M | $89.15M | 0.00% | Add | |
| 14.67M | $71.58M | 0.28% | Hold | |
| 12.99M | $63.37M | 0.35% | Hold | |
| 9.64M | $47.06M | 9.41% | Hold | |
| 9.62M | $46.97M | 0.00% | Add | |
| 7.93M | $38.70M | 2.49% | Reduce | |
| 7.71M | $37.61M | 0.98% | Hold | |
| 7.47M | $36.43M | 0.02% | Reduce | |
| 7.47M | $36.36M | 0.35% | Reduce | |
| 7.29M | $35.58M | 0.00% | Add | |
| 5.94M | $28.99M | 42.65% | Hold | |
| 5.34M | $26.04M | 0.00% | Add | |
| 4.20M | $20.48M | 0.00% | Reduce | |
| 3.95M | $19.28M | 100.00% | Hold | |
| 3.68M | $17.93M | 0.34% | Hold | |
| 3.45M | $16.81M | 0.00% | Add | |
| 3.45M | $16.81M | 0.00% | Add | |
| 3.34M | $16.29M | 0.00% | Add | |
| 3.23M | $15.76M | 0.00% | Reduce | |
| 2.45M | $11.96M | 0.02% | Add | |
| 2.03M | $9.93M | 0.02% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 36.07M | $182.52M | 0.00% | Add | |
| 32.99M | $166.92M | 1.22% | Reduce | |
| 28.37M | $143.56M | 0.01% | Add | |
| 24.17M | $122.32M | 0.09% | Reduce | |
| 14.67M | $74.22M | 0.30% | Hold | |
| 12.99M | $65.71M | 0.35% | Hold | |
| 11.18M | $56.57M | 0.00% | Reduce | |
| 9.67M | $48.91M | 3.45% | Hold | |
| 9.64M | $48.80M | 9.58% | Hold | |
| 8.17M | $41.33M | 0.03% | Reduce | |
| 8.17M | $41.25M | 0.41% | Reduce | |
| 7.78M | $39.35M | 0.00% | Add | |
| 7.71M | $38.99M | 0.90% | Hold | |
| 5.94M | $30.06M | 23.14% | Hold | |
| 5.69M | $28.79M | 0.00% | Add | |
| 5.58M | $28.26M | 0.00% | Reduce | |
| 4.63M | $23.43M | 0.01% | Reduce | |
| 4.62M | $23.35M | 0.01% | Reduce | |
| 3.95M | $19.99M | 17.35% | Hold | |
| 3.68M | $18.60M | 0.41% | Hold | |
| 3.17M | $16.04M | 0.00% | Reduce | |
| 2.91M | $14.75M | 0.00% | Add | |
| 2.59M | $13.10M | 0.00% | Add | |
| 2.59M | $13.10M | 0.00% | Add | |
| 1.88M | $9.51M | 0.01% | Add |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 13.82M sh · $50.72M
- Sixth Street Partners Management Company, L.P. 4.14M sh · $15.19M
- Quadrature Capital Ltd 987.80K sh · $3.63M
- Sender Co & Partners, Inc. 270.20K sh · $991.63K
- Jupiter Topco LLC 220.31K sh · $809.64K
- Soviero Asset Management, LP 200.00K sh · $734.00K
- ALLSTATE CORP 127.71K sh · $468.71K
- Caption Management, LLC 90.00K sh · $330.30K
- Quantitative Investment Management, LLC 88.88K sh · $326.00K
- VIRGINIA RETIREMENT SYSTEMS ET Al 85.70K sh · $314.52K
- WCG Wealth Advisors LLC 73.52K sh · $269.83K
- LaSalle St. Investment Advisors, LLC 68.00K sh · $249.56K
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 28.49M sh · $87.47M
- Renaissance Technologies sold 2.40M sh · $7.37M
- CAPITAL FUND MANAGEMENT S.A. sold 1.91M sh · $5.86M
- Mitsubishi UFJ Trust & Banking Corp sold 908.46K sh · $2.79M
- Janus Henderson Group sold 220.31K sh · $675.25K
- Engineers Gate Manager LP sold 213.84K sh · $656.49K
- Havemeyer Place LP sold 183.94K sh · $564.68K
- Virtu Financial LLC sold 149.72K sh · $460.00K
- Brevan Howard Capital Management LP sold 133.31K sh · $409.28K
- Point72 Asset Management sold 46.30K sh · $142.14K
- IEQ CAPITAL, LLC sold 40.05K sh · $122.95K
- Polymer Capital Management (US) LLC sold 39.88K sh · $122.44K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 53.48M | 50.30M | 43.19M | 38.87M | 31.74M | 28.37M | 23.51M | 23.44M | 20.74M | — | — | — | — | — | — | — | — | — | — | — |
| ARK Invest | 44.75M | 41.34M | 40.21M | 37.32M | 33.55M | 32.99M | 34.82M | 32.35M | 32.77M | 28.14M | 24.59M | 20.65M | 6.88M | 4.74M | 3.58M | 3.10M | 3.36M | 2.73M | 2.83M | 2.23M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 35.81M | 31.13M | 22.76M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 30.00M | — | 28.49M | 25.33M | 18.27M | 11.18M | 13.09M | 12.58M | 12.87M | 8.75M | 10.35M | 12.15M | 11.76M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 23.00M | 22.77M | 22.24M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Baillie Gifford & Co | 18.17M | 23.49M | 23.68M | 23.77M | 23.98M | 24.17M | 24.39M | 24.86M | 25.24M | 26.59M | 24.07M | 24.18M | 24.55M | 25.10M | 25.14M | 24.82M | 21.59M | 21.61M | 21.98M | 22.12M |
| Geode Capital Management | 13.91M | 13.82M | 12.28M | 10.93M | 9.62M | 7.78M | 6.44M | 6.09M | 5.43M | 4.78M | 3.45M | 3.33M | 3.14M | 2.81M | 2.74M | 2.61M | 2.33M | 1.51M | 1.29M | 1.29M |
| Fidelity Management & Research (FMR) | 11.44M | 46.36K | 736.65K | 3.24M | 3.23M | 5.58M | 6.85M | 7.07M | 8.36M | 8.19M | 9.26M | 10.90M | 10.69M | 4.56M | 4.76M | 4.47M | 4.25M | 2.84M | 2.15M | 1.53M |
| UBS Group AG | 8.43M | 8.95M | 43.15K | 43.15K | 188.10K | 4.63M | 5.57M | 3.00M | 799.86K | 1.65M | 672.43K | 691.91K | 342.68K | 168.72K | 168.94K | 361.89K | 18.46K | 4.99K | 6.93K | 259.22K |
| MIC Capital Management UK LLP | 8.26M | 9.64M | 9.64M | 9.64M | 9.64M | 9.64M | 9.64M | 9.64M | 8.45M | 8.45M | 8.45M | 8.45M | 8.45M | — | — | — | — | — | — | — |
| Morgan Stanley | 6.22M | 2.74M | 2.19M | 5.66M | 7.29M | 5.69M | 5.01M | 2.86M | 1.88M | 1.77M | 1.96M | 2.58M | 806.62K | 390.23K | 259.37K | 333.17K | 275.94K | 221.70K | 140.60K | 115.50K |
| Sumitomo Mitsui Trust Group, Inc. | 4.94M | 5.51M | 5.42M | 6.22M | 7.47M | 8.17M | 8.48M | 8.98M | 9.77M | 9.99M | 10.36M | 9.20M | 3.52M | — | — | — | — | — | — | — |
| Amova Asset Management Americas, Inc. | 4.94M | 5.51M | 5.42M | 6.22M | 7.47M | 8.17M | 8.41M | 8.91M | 9.69M | 9.93M | 10.36M | 9.20M | 3.52M | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 3.55M | 3.04M | 2.61M | 2.27M | 1.80M | 1.88M | 1.03M | — | — | 94.85K | 377.73K | 252.69K | 234.42K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 3.54M | 3.47M | 3.51M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 2.68M | 2.60M | 2.56M | 2.40M | 1.77M | 911.09K | 387.24K | 200.47K | 82.35K | 40.25K | — | — | — | — | — | — | — | — | — | — |
| Jump Financial, LLC | 2.50M | 1.02M | 889.93K | 661.63K | 555.08K | 1.15M | 592.35K | 13.49K | — | — | — | — | 253.46K | — | — | — | — | — | — | — |
| MFS Investment Management | 2.39M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 950.59K | 1.33M | 1.34M | 1.30M |
| Marshall Wace | 2.07M | 4.71M | 2.88M | 226.61K | 78.26K | 86.31K | 333.61K | — | — | — | 391.52K | — | — | — | 514.14K | — | — | 106.79K | — | — |
| Nuveen, LLC | 1.91M | 1.72M | 1.16M | 1.08M | 1.28M | 1.23M | 1.91M | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold RXRX?
As of 2026-Q2, 362 institutional funds reported holding RXRX (RECURSION PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $1.29B.
How many shares of RXRX do institutions own?
13F filers reported 350.64M shares of RXRX, worth $1.29B in aggregate at the end of 2026-Q2.
Is institutional ownership of RXRX rising or falling?
Share counts moved +7.4% versus the prior quarter — accumulation.
Who are the top institutional holders of RXRX?
The largest 13F holders are BlackRock Inc, Vanguard Group, ARK Invest, VANGUARD PORTFOLIO MANAGEMENT LLC, STATE STREET CORP; the top 25 are ranked at the top of this page.
Who are the major shareholders of RECURSION PHARMACEUTICALS IN?
The major shareholders of RECURSION PHARMACEUTICALS IN (RXRX) by reported 13F value are BlackRock Inc, Vanguard Group, ARK Invest, VANGUARD PORTFOLIO MANAGEMENT LLC, STATE STREET CORP, among 679 institutional holders.
Which legendary investors own RXRX?
1 of the legendary investors tracked on HoldingsHub report RXRX (RECURSION PHARMACEUTICALS IN) in their latest 13F filings, led by ARK Invest. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on RXRX?
1 tracked superinvestors hold RXRX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.